Net profit of Anthem Biosciences rose 129.68% to Rs 189.76 crore in the quarter ended March 2026 as against Rs 82.62 crore during the previous quarter ended March 2025. Sales rose 26.44% to Rs 610.94 crore in the quarter ended March 2026 as against Rs 483.20 crore during the previous quarter ended March 2025.
For the full year,net profit rose 31.14% to Rs 591.79 crore in the year ended March 2026 as against Rs 451.26 crore during the previous year ended March 2025. Sales rose 15.17% to Rs 2124.33 crore in the year ended March 2026 as against Rs 1844.55 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 610.94 | 483.20 | 26 | 2124.33 | 1844.55 | 15 |
| OPM % | 43.74 | 40.40 | - | 39.25 | 36.37 | - |
| PBDT | 316.53 | 208.73 | 52 | 982.70 | 746.24 | 32 |
| PBT | 276.94 | 178.31 | 55 | 848.63 | 656.87 | 29 |
| NP | 189.76 | 82.62 | 130 | 591.79 | 451.26 | 31 |
Powered by Capital Market - Live News